Marc Engelhardt

Chief Tech/Sci/R&D Officer at BASILEA PHARMACEUTICA AG

Net worth: 1 M $ as of 2026-06-29

62 year

Health Technology

Consumer Services

Profile

Marc Engelhardt is currently Chief Medical Officer at Basilea Pharmaceutica AG since 2018, with employment at the company starting in 2010.
Formerly, Dr. Engelhardt was Director-Global Program Medical at Novartis Pharma AG.
Education includes undergraduate and doctorate degrees from Johann Wolfgang Goethe-Universität Frankfurt am Main.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
BASILEA PHARMACEUTICA AG 0.12%	2025-12-30	16,061 ( 0.12% )	1 M $	2026-06-29

Marc Engelhardt active positions

Companies	Position	Start
BASILEA PHARMACEUTICA AG	Chief Tech/Sci/R&D Officer	2017-12-31

All active positions of Marc Engelhardt

Former positions of Marc Engelhardt

Companies	Position	End
Novartis Pharma AG Novartis Pharma AG Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company	Corporate Officer/Principal	-

See the detail of Marc Engelhardt's experience

Training of Marc Engelhardt

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Marc Engelhardt's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	3
Basilea Pharmaceutica AG Basilea Pharmaceutica AG Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products	Health Technology
Johann Wolfgang Goethe-Universität Frankfurt am Main Johann Wolfgang Goethe-Universität Frankfurt am Main Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Novartis Pharma AG Novartis Pharma AG Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company	Health Technology